Rockwell Medical Technologies (RMTI) Posts Wider than Expected Q4 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $7.06 -0.28%
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q4 loss of $0.49, versus he analyst estimate of ($0.22). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $13.55 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- First Bank (FRBA) Tops Q3 EPS by 5c
- Oregon Pacific Bancorp (ORPB) Tops Q3 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
